| OzAurum Resources Limited (OZM) ORDINARY FULLY PAID |
Materials |
$25 |
Correction to Mineral Resource Table
|
1 Apr 2026 9:34AM |
$0.086 |
$0.088 |
risen by
2.33%
|
|
| Perenti Limited (PRN) ORDINARY FULLY PAID |
Materials |
$1,985 |
Appointment of Managing Director and CEO
|
1 Apr 2026 9:34AM |
$1.950 |
$2.120 |
risen by
8.72%
|
|
PRN - Price-sensitive ASX Announcement
Full Release
Key Points
- Appointment of Dr Vanessa Torres as Managing Director & CEO
- Dr Torres's extensive global mining experience
- Leadership transition from Mark Norwell to Vanessa Torres
- Significant revenue growth under Mr Norwell
- Strategic focus on long-term sustainable growth
- Dr Torres to commence role on June 1, 2026
- Compensation includes a salary of $1,250,000 and incentive plans
- Comprehensive search process by the Perenti Board
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| JB Hi-Fi Limited (JBH) ORDINARY FULLY PAID |
Consumer Discretionary |
$7,811 |
Notification regarding unquoted securities - JBH
|
1 Apr 2026 9:34AM |
$72.420 |
$71.440 |
fallen by
1.35%
|
|
| iCandy Interactive Limited (ICI) ORDINARY FULLY PAID |
Communication Services |
$20 |
Removal from Official List
|
1 Apr 2026 9:34AM |
$0.016 |
$0.016 |
fallen by
0%
|
|
| Verity Resources Limited (VRL) ORDINARY FULLY PAID |
Materials |
$8 |
Sampling Over New Gold Geophysical Targets Commenced
|
1 Apr 2026 9:32AM |
$0.020 |
$0.017 |
fallen by
15%
|
|
VRL - Price-sensitive ASX Announcement
Full Release
Key Points
- Systematic first-pass soil sampling campaign commenced at Monument Gold Project.
- Focus on newly granted Gum Well area and follow-up at Star Well, McKenzie Well, and McKenzie Granite.
- Objective to expand exploration and generate new drill targets.
- The campaign supports Verity's district-scale growth strategy.
- Potential for various styles of gold mineralisation due to geological diversity.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Fortifai Ltd (FTI) ORDINARY FULLY PAID |
Communication Services |
$250 |
Nol8 Testing Against Google RE2 Delivers World-First Results
|
1 Apr 2026 9:32AM |
$0.400 |
$0.730 |
risen by
82.50%
|
|
FTI - Price-sensitive ASX Announcement
Full Release
Key Points
- Nol8 demonstrated a 200,000x throughput advantage over Google's RE2 engine.
- Nol8's FPGA-accelerated engine maintains 1,500 MB/s throughput consistently.
- Google's RE2 engine performance degrades under high complexity and load.
- Nol8 technology aims to overcome data processing scalability constraints.
- Future benchmarking plans to explore full limits of Nol8's technology.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| GPT Group (GPT) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$9,080 |
Change of Director's Interest Notice - Russell Proutt
|
1 Apr 2026 9:31AM |
$4.530 |
$4.740 |
risen by
4.64%
|
|
| Solstice Minerals Limited (SLS) ORDINARY FULLY PAID |
Materials |
$274 |
Trading Halt
|
1 Apr 2026 9:30AM |
$1.110 |
$1.590 |
risen by
43.24%
|
|
SLS - Price-sensitive ASX Announcement
Full Release
Key Points
- Trading halt requested by Solstice Minerals Limited.
- The securities of SLS will be halted pending a capital raising announcement.
- Trading halt expected to last until the announcement or until 7 April 2026.
- Request for trading halt made in accordance with ASX Listing Rule 17.1.
- Solstice Minerals Limited unaware of any reason the halt should not be granted.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Polynovo Limited (PNV) ORDINARY FULLY PAID |
Health Care |
$736 |
Initial Director's Interest Notice - Charmaine Gittleson
|
1 Apr 2026 9:30AM |
$0.935 |
$1.065 |
risen by
13.90%
|
|
| GPT Group (GPT) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$9,080 |
Notification regarding unquoted securities - GPT
|
1 Apr 2026 9:29AM |
$4.530 |
$4.740 |
risen by
4.64%
|
|
| Eagers Automotive Limited (APE) ORDINARY FULLY PAID |
Consumer Discretionary |
$5,865 |
Update on Growth Initiatives and CanadaOne Auto Completion
|
1 Apr 2026 9:29AM |
$22.500 |
$20.770 |
fallen by
7.69%
|
|
APE - Price-sensitive ASX Announcement
Full Release
Key Points
- Eagers Automotive Limited (ASX: APE) is progressing with strategic investments and acquisitions.
- The company is working towards completing its investment in CanadaOne Auto, with completion expected in Q2 2026.
- Eagers Automotive has entered a non-binding term sheet to acquire a strategic stake in Grand Motors Group's multi-brand dealerships in Sydney and Gold Coast.
- The Grand Motors Group generated approximately $490 million in revenue for the year ending December 2025.
- Eagers Automotive is expanding its Audi brand representation through the acquisition of Audi Centre Melbourne and Audi Richmond.
- The Audi dealerships acquisition is expected to be completed by the end of May 2026.
- Eagers Automotive is actively collaborating with CanadaOne Auto and their OEM partners to complete the transaction.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Enlitic Inc (ENL) CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED |
Health Care |
$6 |
Notice of Annual General Meeting/Proxy Form
|
1 Apr 2026 9:28AM |
$0.007 |
$0.007 |
fallen by
0%
|
|
| Garda Diversified Property Fund (GDF) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$223 |
GDF AMIT Fund Payment Notice
|
1 Apr 2026 9:28AM |
$1.125 |
$1.025 |
fallen by
8.89%
|
|
| Ophir High Conviction Fund (OPH) ORDINARY UNITS FULLY PAID |
Financials |
$565 |
Month End NTA - 31.03.2026
|
1 Apr 2026 9:28AM |
$2.670 |
$2.540 |
fallen by
4.87%
|
|
| Australian Clinical Labs Limited (ACL) ORDINARY FULLY PAID |
Health Care |
$388 |
Update - Notification of buy-back - ACL
|
1 Apr 2026 9:24AM |
$2.080 |
$2.070 |
fallen by
0.48%
|
|
| Buxton Resources Limited (BUX) ORDINARY FULLY PAID |
Materials |
$18 |
Trading Halt
|
1 Apr 2026 9:24AM |
$0.042 |
$0.042 |
fallen by
0%
|
|
BUX - Price-sensitive ASX Announcement
Full Release
Key Points
- Buxton Resources Limited requested a trading halt on its securities.
- The trading halt is pending an announcement of a capital raising.
- Securities will remain in a trading halt until April 7, 2026, or an announcement is made.
- Buxton Resources is not aware of any reason why the trading halt should not be granted.
- The request for the trading halt was made in accordance with ASX Listing Rule 17.1.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bougainville Copper Limited (BOC) 1 KINA ORDINARY FULLY PAID |
Materials |
$243 |
Suspension from Quotation
|
1 Apr 2026 9:23AM |
$0.635 |
$0.605 |
fallen by
4.72%
|
|
BOC - Price-sensitive ASX Announcement
Full Release
Key Points
- Suspension of Bougainville Copper Limited's securities from quotation
- Suspension due to failure to lodge a periodic report
- Suspension effective from 1 April 2026
- Reinstatement of securities possible after report submission
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Energy Transition Minerals Ltd (ETM) ORDINARY FULLY PAID |
Materials |
$132 |
Update regarding Kvanefjeld Project
|
1 Apr 2026 9:23AM |
$0.086 |
$0.060 |
fallen by
30.23%
|
|
ETM - Price-sensitive ASX Announcement
Full Release
Key Points
- ETM faces uncertainty over exploration license extension for Kvanefjeld Project.
- Greenlandic authorities have provided no reason for potentially denying the extension.
- ETM had previously engaged with authorities regarding license extension conditions.
- Denial of extension could support ETM's legal position regarding an exploitation license.
- ETM is committed to protecting its rights and interests in the Kvanefjeld Project.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AML3D Limited (AL3) ORDINARY FULLY PAID |
Industrials |
$81 |
ARCEMY X OPERATIONAL AT US DEFENCE SUPPLIER FASTECH
|
1 Apr 2026 9:23AM |
$0.200 |
$0.145 |
fallen by
27.50%
|
|
AL3 - Price-sensitive ASX Announcement
Full Release
Key Points
- AML3D Limited completed the ARCEMY® X system installation on schedule at FasTech LLC.
- The installation is worth approximately A$1.7 million and enhances FasTech's 3D printing capabilities.
- This project strengthens AML3D's presence in the US defence and industrial manufacturing markets.
- AML3D is increasing its manufacturing capacity in Stow, Ohio, to meet rising US demand.
- The project supports AML3D’s strategic expansion into new industrial markets beyond defence.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Turaco Gold Limited (TCG) ORDINARY FULLY PAID |
Materials |
$511 |
Application for quotation of securities - TCG
|
1 Apr 2026 9:21AM |
$0.610 |
$0.485 |
fallen by
20.49%
|
|
| Coast Entertainment Holdings Limited (CEH) ORDINARY FULLY PAID |
Consumer Discretionary |
$165 |
Correction - Appendix 3Y - David Haslingden
|
1 Apr 2026 9:21AM |
$0.475 |
$0.425 |
fallen by
10.53%
|
|
| GCM Corporation Limited (GCM) ORDINARY FULLY PAID |
Materials |
$32 |
Initial VHD Product Range Launched
|
1 Apr 2026 9:21AM |
$0.011 |
$0.011 |
fallen by
0%
|
|
GCM - Price-sensitive ASX Announcement
Full Release
Key Points
- GCM launches initial VHD heat sink product range.
- Products available for purchase on GCM's website.
- Targets BGA devices used in multiple industries.
- Plans to expand product range with more heat sinks.
- VHD technology offers higher thermal conductivity and lower weight.
- Commercialization strategy includes third-party sales and partnerships.
- Strong interest from prospective customers and industry participants.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AdAlta Limited (1AD) ORDINARY FULLY PAID |
Health Care |
$11 |
BZDS1901 clinical update
|
1 Apr 2026 9:20AM |
$0.004 |
$0.004 |
fallen by
0%
|
|
1AD - Price-sensitive ASX Announcement
Full Release
Key Points
- AdAlta Limited reported positive results from Gen 2 BZDS1901 trials in China.
- Gen 2 BZDS1901 demonstrated a 50% ORR and a 20% CR rate in advanced mesothelioma.
- Updated safety protocols allowed higher doses with manageable toxicities.
- The trials are part of AdAlta's strategy to introduce BZDS1901 to Western markets.
- Gen 2 BZDS1901 features a cost-effective and scalable manufacturing process.
- The therapy targets mesothelin, a protein found in aggressive cancers.
- AdAlta's CEO emphasized the potential impact of BZDS1901 for mesothelioma patients.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Dexus (DXS) FULLY PAID UNITS STAPLED SECURITIES |
Real Estate |
$5,867 |
Notification of cessation of securities - DXS
|
1 Apr 2026 9:20AM |
$5.920 |
$5.470 |
fallen by
7.60%
|
|
| AVITA Medical, Inc. (AVH) CHESS DEPOSITARY INTERESTS 5:1 |
Health Care |
$180 |
AVITA Shelf Registration Statement Filed with the SEC
|
1 Apr 2026 9:20AM |
$1.075 |
$1.173 |
risen by
9.07%
|
|
AVH - Price-sensitive ASX Announcement
Full Release
Key Points
- AVITA Medical filed a Shelf Registration Statement with the SEC.
- The registration allows for the sale of up to $200 million in securities.
- No immediate plans to offer securities under this registration.
- RECELL® technology is central to AVITA Medical's offerings.
- Proceeds from offerings will be used for general corporate purposes.
- AVITA's securities are listed on Nasdaq and ASX.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.